For research and educational purposes only. Not medical advice.
Aniracetam Reference
Educational, not medical advice reference for Aniracetam: Nootropic, Cognitive; regulatory status, evidence posture, source review, and schedule notes. Also…
Reference summary
Smaller human literature than piracetam, primarily small trials in cognitive impairment and anxiety. Lipid-soluble; pharmacokinetics differ from piracetam.
- Categories
- Nootropic, Cognitive
- Aliases
- Draganon, Sarpul, Ampamet, Memodrin, Ro 13-5057
- Evidence posture
- human — Not FDA-approved in the US. Smaller human evidence base than piracetam. Community nootropic framing for healthy adults outruns the published trials.
- Regulatory status
- No FDA-approved aniracetam drug label. Approved in some non-US markets for memory / cognitive impairment. Sold in the US only through research-chemical channels.
- Content review status
- research reference